Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Axcan receives approvable letter for Photofrin

Dec. 4, 2002

Enrollment completed in phase III trial of ABI-007

Dec. 4, 2002

Taxotere approved for first-line therapy in NSCLC

Dec. 4, 2002

Human Genome Sciences and Kirin announce license agreement

Dec. 4, 2002

Corixa withdraws dispute resolution as FDA returns Bexxar to active review status

Dec. 4, 2002

Telomerase inhibitor with potential as an antitumor and radiosensitizing agent

Dec. 4, 2002

Sulfonyhydrazine prodrug VNP-40101M advances towards phase II clinical evaluation

Dec. 4, 2002

SU-11248: preclinical and early clinical findings encourage further development

Dec. 4, 2002

Improved survival rate found with 131I-ch81C6 in malignant brain tumors

Dec. 4, 2002

Promising toxicity and antitumor efficacy for temozolomide + vatalanib succinate in glioblastoma

Dec. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...